| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of Ethics Committees in Europe on issues related to clinical trials in paediatrics: Results of a survey
|
Altavilla, A.
|
|
2009
|
|
1-2 |
p. 79-87
|
artikel
|
| 2 |
Advanced therapy medicinal products: Gene therapy
|
Ayala, Antonio
|
|
2015
|
|
1-2 |
p. 253-264
|
artikel
|
| 3 |
Adverse drug reactions reporting in children
|
Verhamme, K.
|
|
2009
|
|
1-2 |
p. 89-99
|
artikel
|
| 4 |
A public health perspective on the effectiveness of European pharmaceutical regulation
|
Bauschke, Rafael
|
|
2011
|
|
1-2 |
p. 91-114
|
artikel
|
| 5 |
A single European pharmaceutical market: Does maximum harmonization enhance medicinal product innovation?
|
Faeh, Andrea
|
|
2013
|
|
1-2 |
p. 7-27
|
artikel
|
| 6 |
Availability of medicines for rare diseases in EU Countries
|
Trama, Annalisa
|
|
2009
|
|
1-2 |
p. 101-109
|
artikel
|
| 7 |
Chemical, pharmaceutical and biological information for medicinal products containing chemical and/or biological active substances
|
Übeda, Antonio Espinosa
|
|
2015
|
|
1-2 |
p. 65-79
|
artikel
|
| 8 |
CJD virus, contaminated medicine and prevention technology
|
Akhtar, Zia
|
|
2013
|
|
1-2 |
p. 37-50
|
artikel
|
| 9 |
Clinical trials
|
Pineda, Jaime Algorta
|
|
2015
|
|
1-2 |
p. 117-152
|
artikel
|
| 10 |
Clinical trials for paediatric medicines in Europe
|
Baiardi, P.
|
|
2009
|
|
1-2 |
p. 71-78
|
artikel
|
| 11 |
Computerisation of medical prescriptions and electronic circulation of prescriptions in Italy: Changing legislation and European principles
|
Bottari, Carlo
|
|
2017
|
|
1-2 |
p. 33-45
|
artikel
|
| 12 |
Cross-border healthcare and recognition of medical prescriptions issued in another Member State
|
Bombillar Sáenz, Francisco Miguel
|
|
2017
|
|
1-2 |
p. 47-61
|
artikel
|
| 13 |
Data protection and market exclusivities for pharmaceuticals in the EU
|
Cook, Trevor
|
|
2014
|
|
1-2 |
p. 19-43
|
artikel
|
| 14 |
Erratum
|
|
|
2014
|
|
1-2 |
p. 173
|
artikel
|
| 15 |
EU marketing authorization subsequent to dissolution of the transferor and prior to effective transfer
|
Ghazarian, Lucyne
|
|
2013
|
|
1-2 |
p. 29-35
|
artikel
|
| 16 |
European pharmaceutical harmonisation
|
Sauer, Fernand
|
|
2015
|
|
1-2 |
p. 9-15
|
artikel
|
| 17 |
Herbal medicinal products
|
Gupta, Mahabir P.
|
|
2015
|
|
1-2 |
p. 231-249
|
artikel
|
| 18 |
Homeopathic medicines
|
Barelli, Bienvenido
|
|
2015
|
|
1-2 |
p. 221-229
|
artikel
|
| 19 |
Illegal medicines as threats to public health
|
Valverde, José Luis
|
|
2017
|
|
1-2 |
p. 1-16
|
artikel
|
| 20 |
Innovative Medicines development in Europe
|
|
|
2010
|
|
1-2 |
p. 3-4
|
artikel
|
| 21 |
New paediatric research initiatives in the European Union
|
Donnelly, Fergal
|
|
2009
|
|
1-2 |
p. 3-9
|
artikel
|
| 22 |
Non-clinical reports
|
Herrera, Maria Dolores
|
|
2015
|
|
1-2 |
p. 91-100
|
artikel
|
| 23 |
Non-patent protection of pharmaceuticals in Japan
|
Niioka, Hidero
|
|
2014
|
|
1-2 |
p. 125-166
|
artikel
|
| 24 |
Non-patent protection of pharmaceuticals in the USA
|
Thomas, John R.
|
|
2014
|
|
1-2 |
p. 89-123
|
artikel
|
| 25 |
Off-label and unlicensed use of medicines for children
|
Neubert, A.
|
|
2009
|
|
1-2 |
p. 41-49
|
artikel
|
| 26 |
Paediatric status and off-label use of drugs in children in Italy, United Kingdom and the Netherlands
|
Sturkenboom, M.
|
|
2009
|
|
1-2 |
p. 51-59
|
artikel
|
| 27 |
Particular medicinal products
|
Ruiz-Bravo, Alfonso
|
|
2015
|
|
1-2 |
p. 165-189
|
artikel
|
| 28 |
Pharmaceutical innovation and non-patent protection
|
|
|
2014
|
|
1-2 |
p. 1-3
|
artikel
|
| 29 |
Pharmaceutical products
|
Széliga, María Emilia
|
|
2015
|
|
1-2 |
p. 81-89
|
artikel
|
| 30 |
Pharmaceuticals liability for defective products in Spain
|
Cabezas, María-Dolores
|
|
2017
|
|
1-2 |
p. 87-102
|
artikel
|
| 31 |
Pharmacoeconomic evidence and policies to promote use of generic medicines in Jordan
|
El-Dahiyat, Faris
|
|
2017
|
|
1-2 |
p. 71-86
|
artikel
|
| 32 |
Pharmacovigilance and risk management in the EU
|
López, María Dolores Cabezas
|
|
2013
|
|
1-2 |
p. 71-84
|
artikel
|
| 33 |
Political and regulatory key factors of transparency and independence in terms of vaccination in Spain: Information, participation and lobbies
|
Cuenca, Nuria María Garrido
|
|
2017
|
|
1-2 |
p. 103-120
|
artikel
|
| 34 |
Prologue
|
Ramos-Cormenzana, Alberto
|
|
2015
|
|
1-2 |
p. 5-7
|
artikel
|
| 35 |
Providing the chronically ill with medications in Bulgaria
|
Stoyanova, Rumyana
|
|
2017
|
|
1-2 |
p. 63-70
|
artikel
|
| 36 |
Recent developments in the area of supplementary protection certificates
|
Gassner, Ulrich M.
|
|
2014
|
|
1-2 |
p. 45-72
|
artikel
|
| 37 |
Recommendations for drug development for children
|
Catapano, M.
|
|
2009
|
|
1-2 |
p. 61-70
|
artikel
|
| 38 |
Registration dossier for radiopharmaceutical products
|
Mallol, J.
|
|
2015
|
|
1-2 |
p. 213-220
|
artikel
|
| 39 |
Regulatory harmonisation for better global health
|
Valverde, Jose Luis
|
|
2015
|
|
1-2 |
p. 17-22
|
artikel
|
| 40 |
Relations between SPC and data exclusivity
|
Zbierska, Katarzyna
|
|
2014
|
|
1-2 |
p. 73-87
|
artikel
|
| 41 |
Specific marketing authorisation dossiers and requirements
|
Asuero, A.G.
|
|
2015
|
|
1-2 |
p. 155-161
|
artikel
|
| 42 |
Specific requirements for somatic cell therapy medicinal products and tissue engineered products
|
Martín, Rosa M. Hernández
|
|
2015
|
|
1-2 |
p. 271-277
|
artikel
|
| 43 |
Specific requirements regarding module 4
|
González, Maria Dolores Herrera
|
|
2015
|
|
1-2 |
p. 265-270
|
artikel
|
| 44 |
Specific requirements regarding module 5
|
Hernández Martín, Rosa M.
|
|
2015
|
|
1-2 |
p. 279-281
|
artikel
|
| 45 |
Summary
|
Cabezas, María Dolores
|
|
2015
|
|
1-2 |
p. 49-64
|
artikel
|
| 46 |
TEDDY EPMD: A European Paediatric Medicines Database
|
Felisi, M.
|
|
2009
|
|
1-2 |
p. 31-39
|
artikel
|
| 47 |
TEDDY Network of Excellence: Monograph on paediatric medicines
|
Ceci, Adriana
|
|
2009
|
|
1-2 |
p. 11-12
|
artikel
|
| 48 |
TEDDY NoE project in the framework of the EU Paediatric Regulation
|
Ceci, A.
|
|
2009
|
|
1-2 |
p. 13-21
|
artikel
|
| 49 |
The administrative information of the registration of a medicinal product dossier
|
Cabezas, María Dolores
|
|
2015
|
|
1-2 |
p. 35-48
|
artikel
|
| 50 |
The Common Technical Document as academic guideline
|
|
|
2015
|
|
1-2 |
p. 1-3
|
artikel
|
| 51 |
The common technical document as basis of the authorization of marketing of medicinal products in the European Union
|
Cabezas, María Dolores
|
|
2015
|
|
1-2 |
p. 23-31
|
artikel
|
| 52 |
The influence of TRIPs on the non-patent protection of pharmaceuticals
|
Cook, Trevor
|
|
2014
|
|
1-2 |
p. 5-17
|
artikel
|
| 53 |
The medical devices regulation in the EU ‐ the evolution of the regulatory framework for medical devices
|
Casteels, Brigitte
|
|
2013
|
|
1-2 |
p. 85-92
|
artikel
|
| 54 |
The originality and specificity of medicinal product
|
|
|
2013
|
|
1-2 |
p. 1-5
|
artikel
|
| 55 |
The pharmaceuticals industry in trouble
|
Valverde, José Luis
|
|
2013
|
|
1-2 |
p. 51-69
|
artikel
|
| 56 |
The prevention and detection of corruption in pharmaceutical companies
|
Peltier-Rivest, Dominic
|
|
2017
|
|
1-2 |
p. 17-31
|
artikel
|
| 57 |
The ``priority review vouchers'' for neglected pharmaceutical innovation and their impact on pharmaceutical patents
|
Sanchez, Alfonso Calles
|
|
2014
|
|
1-2 |
p. 167-172
|
artikel
|
| 58 |
The Regulation of Paediatric Medicines in the EU
|
|
|
2009
|
|
1-2 |
p. 1-2
|
artikel
|
| 59 |
The role of paediatric pharmacogenetic studies in Europe
|
Krekels, E.
|
|
2009
|
|
1-2 |
p. 23-30
|
artikel
|
| 60 |
Toxicology
|
Zurita, Antonio Zarzuelo
|
|
2015
|
|
1-2 |
p. 101-116
|
artikel
|
| 61 |
1.2. Vaccines
|
Ruiz-Bravo, Alfonso
|
|
2015
|
|
1-2 |
p. 191-212
|
artikel
|
Tijdschrift beschrijving